Gilead Sciences (GILD) Enterprise Value (2009 - 2026)
Gilead Sciences (GILD) recorded Enterprise Value of $153.52 billion in Q2 2026, up 16.0% from $132.4 billion a year earlier but down 7.2% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Enterprise Value (2009 - 2026) Analysis & Trends
On a TTM basis, Gilead Sciences' Enterprise Value came in at $130.9 billion as of Jun 30, 2026, up 19.6% year-over-year; for FY2025, it was $144.6 billion, up 37.7% from FY2024.
- Annual Enterprise Value has a five-year compound annual growth rate of 17.1% (FY2020 to FY2025).
- Across earlier years, Enterprise Value came in at $105.02 billion in FY2024 (+12.2%), $93.59 billion in FY2023 (-7.0%), $100.64 billion in FY2022 (+19.1%) and $84.53 billion in FY2021 (+28.7%).
- Quarterly Enterprise Value has ranged from $69.27 billion in Q1 2022 to $165.37 billion in Q1 2026 over the past five years.
- On a year-over-year basis, Enterprise Value has increased for eight consecutive quarters, with growth averaging 31.3% over the last eight quarters.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 60.2% in Q2 2025, against a decline of 12.5% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $165.37 billion (Q1 2026), $144.6 billion (Q4 2025) and $130.43 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 135.25 Bn | 107.26 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 153.52 Bn |
| Mar 31, 2026 | 165.37 Bn |
| Dec 31, 2025 | 144.60 Bn |
| Sep 30, 2025 | 130.43 Bn |
| Jun 30, 2025 | 132.40 Bn |
| Mar 31, 2025 | 131.49 Bn |
| Dec 31, 2024 | 105.02 Bn |
| Sep 30, 2024 | 99.34 Bn |
| Jun 30, 2024 | 82.63 Bn |
| Mar 31, 2024 | 86.47 Bn |
| Dec 31, 2023 | 93.59 Bn |
| Sep 30, 2023 | 86.51 Bn |
| Jun 30, 2023 | 89.38 Bn |
| Mar 31, 2023 | 97.62 Bn |
| Dec 31, 2022 | 100.64 Bn |
| Sep 30, 2022 | 71.68 Bn |
| Jun 30, 2022 | 71.83 Bn |
| Mar 31, 2022 | 69.27 Bn |
| Dec 31, 2021 | 84.53 Bn |
| Sep 30, 2021 | 81.92 Bn |
API Access
Gilead Sciences Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();